Prescriber Scope of Practice for Insomnia in Illinois

If you’re a psychiatrist or PMHNP treating insomnia via telehealth, you’ve probably asked yourself: Can I legally prescribe sleep medications online? What about controlled substances like Ambien or benzodiazepines?

The short answer: Yes — under current federal rules, you can prescribe insomnia medications via telehealth, including controlled substances, through December 31, 2026. But the details matter, especially if you’re practicing across multiple states or working as an independent NP.

Federal telehealth flexibilities are still in effect (DEA extended them through 2026), which means you can prescribe Schedule IV sleep aids like zolpidem without an in-person exam. However, state-specific rules around scope of practice, PMHNP independence, and certain prescribing restrictions can significantly impact how you practice — especially in states like Texas, Florida, and Pennsylvania.

This guide breaks down what psychiatrists and PMHNPs need to know about prescribing insomnia medications via telehealth in 2026, including the DEA’s current stance, state-by-state variations, and what’s likely coming next.

Federal Rules: The DEA’s Telehealth Extensions and What They Mean for Insomnia Care

The Ryan Haight Act and Why It Mattered

Before COVID-19, prescribing controlled substances via telehealth was essentially illegal under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. The law required an in-person medical evaluation before any Schedule II–V controlled substance could be prescribed through telemedicine.

For insomnia providers, this meant patients needed at least one face-to-face visit before you could prescribe medications like:

• Zolpidem (Ambien) — Schedule IV
• Eszopiclone (Lunesta) — Schedule IV
• Temazepam (Restoril) — Schedule IV
• Triazolam — Schedule IV
• Other benzodiazepines and orexin antagonists

The pandemic changed everything.

COVID-Era Flexibilities (Still Active in 2026)

Starting in March 2020, the DEA suspended the in-person exam requirement to maintain access to care during the public health emergency. Prescribers could evaluate patients via video (or even audio-only for certain addiction treatments) and issue controlled substance prescriptions — no in-person visit required.

Even after the PHE ended, the DEA repeatedly extended this flexibility. As of December 31, 2025, DEA announced a Fourth Extension through December 31, 2026, citing the need to avoid disrupting patient care while permanent rules are finalized.

What this means for you right now:

• You can prescribe Schedule II–V controlled substances via telehealth without an in-person exam
• The prescription must follow a live audio-video evaluation (audio-only is allowed for FDA-approved opioid addiction treatments)
• You must be DEA-registered and licensed in the patient’s state
• Standard prescribing rules still apply — legitimate medical purpose, standard of care, PDMP checks

For insomnia, this means a psychiatrist in California or a PMHNP in New York can conduct a video visit with a new patient, diagnose insomnia, and prescribe zolpidem or a benzodiazepine — all legally, all online — as long as state law permits it.

What’s Coming: The DEA’s Proposed Permanent Framework

The DEA is working on permanent telehealth prescribing rules to replace these temporary extensions. In January 2025, DEA announced a new proposed framework with two key components:

1. Telemedicine Special Registration (Schedule III–V)
Any DEA-registered practitioner could apply for a special telehealth registration to prescribe Schedule III–V controlled substances online without ever meeting the patient in person. This would cover most insomnia medications (Schedule IV hypnotics, benzodiazepines).

2. Advanced Telemedicine Registration (Schedule II)
Only certain specialists — including psychiatrists — could prescribe Schedule II substances via telehealth. A national PDMP would be implemented as a safeguard.

These rules haven’t been finalized yet, but the 2026 extension gives DEA time to refine and implement the framework. Providers should expect some form of special registration requirement before 2027.

Bottom line: Enjoy the current flexibility, but stay alert for new DEA rules. You’ll likely need to apply for a telemedicine registration or credential once permanent rules take effect — but the core ability to prescribe insomnia meds via telehealth should remain intact.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Common Insomnia Medications and Their Controlled Substance Status

Understanding the scheduling of insomnia medications helps you navigate both federal DEA rules and state-specific prescribing laws.

Schedule IV Medications (Most Common)

Most dedicated insomnia treatments are Schedule IV — considered lower-risk than opioids or stimulants but still regulated:

Non-benzodiazepine hypnotics (‘Z-drugs’):

• Zolpidem (Ambien)
• Eszopiclone (Lunesta)
• Zaleplon

Benzodiazepines:

• Temazepam (Restoril)
• Triazolam
• Lorazepam (used off-label)
• Clonazepam (used off-label)

Orexin receptor antagonists:

• Suvorexant (Belsomra)
• Lemborexant

Schedule IV Prescribing Rules

• Maximum 5 refills within 6 months
• Prescription must be for legitimate medical purpose
• Require DEA registration and state controlled substance license
• Subject to PDMP reporting and query requirements
• Electronic prescribing often required (state-specific)

Non-Controlled Options

Several insomnia treatments are not controlled substances, making them simpler to prescribe via telehealth:

• Trazodone (antidepressant used off-label for sleep)
• Doxepin (low-dose tricyclic)
• Ramelteon (melatonin receptor agonist)
• OTC antihistamines (diphenhydramine, doxylamine)

These can be prescribed without DEA registration or PDMP checks, though you still need appropriate licensure and standard of care.

Prescribing Best Practices

Even under the current telehealth flexibility, you should:

• Check the state PDMP before prescribing any controlled substance (many states mandate this)
• Document a thorough sleep history — onset, duration, precipitating factors, sleep hygiene
• Screen for medical causes — sleep apnea, restless legs, medication side effects
• Consider non-pharmacological interventions — CBT-I, sleep hygiene education
• Start low, go slow — lowest effective dose, shortest duration
• Monitor for dependence — especially with benzodiazepines
• Use electronic prescribing where required by state law

The standard of care via telehealth should equal in-person care. That means a proper diagnostic evaluation, not just handing out prescriptions.

Psychiatrist Scope of Practice: You’re Fully Authorized

If you’re a psychiatrist (MD or DO), treating insomnia is squarely within your scope of practice in every state. No exceptions, no restrictions.

Why Psychiatrists Are Ideal for Insomnia Care

Insomnia often has psychological underpinnings — anxiety, depression, stress, trauma. As a psychiatrist, you can:

• Diagnose primary insomnia vs. insomnia secondary to psychiatric conditions
• Provide psychotherapy including CBT-I or behavioral sleep interventions
• Prescribe any necessary medications — controlled or non-controlled
• Manage complex cases — comorbid psychiatric disorders, medication interactions
• Address the whole patient — not just symptoms but root causes

Prescriptive Authority: No Supervision Required

As a physician, you have unrestricted prescriptive authority:

• You can prescribe any Schedule II–V controlled substance with your DEA registration
• No physician supervision or collaboration required (unlike NPs in many states)
• No prescribing limits beyond standard medical board expectations
• Full telehealth privileges in any state where you’re licensed

The only regulatory considerations are the general ones:

• Maintain state medical license in the patient’s state
• Follow DEA and state controlled substance laws
• Meet the standard of care to avoid board discipline
• Document appropriately to defend prescribing decisions

Malpractice and Standard of Care

State medical boards expect you to follow evidence-based protocols:

• Screen for sleep apnea before assuming primary insomnia
• Consider CBT-I as first-line for chronic insomnia (per clinical guidelines)
• Use medications conservatively — short-term or intermittent, not indefinite high-dose
• Document your reasoning — why this medication, why this dose, what alternatives were considered
• Monitor and reassess — periodic follow-ups to evaluate effectiveness and safety

Following these principles protects you legally and clinically. A psychiatrist who documents a thorough evaluation, discusses behavioral strategies, and uses controlled medications judiciously has wide latitude to treat insomnia however they see fit.

PMHNP Scope of Practice: State-by-State Variation

If you’re a psychiatric nurse practitioner, your ability to independently diagnose and treat insomnia — especially prescribing controlled substances — depends entirely on your state’s practice laws.

Three Categories of NP Practice Authority

Full Practice Authority (FPA):
NPs can evaluate, diagnose, and prescribe independently without physician oversight.

Examples:

• New York — Independent practice after 3,600 hours under collaboration
• Illinois — FPA after 4,000 hours and additional training
• California — Transitioning to FPA (experienced NPs can practice independently in certain settings as of 2023)

Reduced Practice:
NPs can perform many tasks independently but need a collaborative agreement with a physician, especially for prescribing.

Examples:

• Pennsylvania — Requires collaborative agreement for all prescribing
• New York (for new NPs before 3,600 hours) — Must practice under physician collaboration

Restricted Practice:
NPs require direct physician supervision or delegation to practice.

Examples:

• Texas — Requires Prescriptive Authority Agreement; NPs cannot prescribe Schedule II in outpatient settings
• Florida — PMHNPs require supervising physician protocol (autonomous practice not yet available for psych NPs)

What This Means for Insomnia Practice

In FPA states (New York, Illinois, California for experienced NPs):

• You can open an independent telehealth insomnia practice
• Prescribe Schedule IV sleep medications on your own authority
• No physician sign-off required (though you still need your own DEA registration)

In reduced/restricted states (Texas, Florida, Pennsylvania):

• You need a collaborating physician on record
• That physician must explicitly delegate controlled substance prescribing in your agreement
• Some states limit what schedules you can prescribe (e.g., Texas NPs cannot prescribe Schedule II outpatient)
• You may need periodic physician chart review or consultation

For telehealth across state lines:

• No universal APRN compact (unlike RN compact)
• You need a license in every state where patients are located
• Some states offer telehealth registration (e.g., Florida) without full licensure
• Scope of practice follows the patient’s state, not yours

Controlled Substance Prescribing by NPs

All 50 states allow NPs to prescribe controlled substances, but conditions vary:

Common requirements:

• Personal DEA registration
• State controlled substance license or registration
• Physician collaboration or delegation (in non-FPA states)
• Additional training or certification in some states

Common restrictions:

• Texas: No Schedule II prescribing in outpatient settings (doesn’t affect most insomnia meds)
• Florida: 7-day limit on Schedule II for non-psych APRNs (PMHNPs exempt)
• Pennsylvania: Collaborative agreement must explicitly authorize controlled substance prescribing

For insomnia (mostly Schedule IV):

• Most states don’t impose additional restrictions on Schedule IV beyond collaboration requirements
• Key exceptions: states with specific telehealth bans on controlled substances (we’ll cover below)
• PDMP checks often required before prescribing benzodiazepines or any controlled substance

Bottom line for NPs: Know your state’s collaboration requirements and any schedule-specific limits. In many states, a PMHNP under proper physician collaboration can manage insomnia identically to a psychiatrist — but the administrative burden is higher.

State-by-State Telehealth Prescribing Rules for Insomnia

Federal DEA rules allow telehealth prescribing of controlled substances through 2026. But state laws can impose additional restrictions — especially around which controlled substances can be prescribed via telehealth and under what conditions.

Here’s what you need to know for the six priority states.

California

Licensing:

• Must hold California medical license (physicians) or RN + NP certification (NPs)
• No special telehealth license available
• Not in Interstate Medical Licensure Compact (physicians) or APRN Compact (NPs)

NP Scope:

• AB 890 (2023) created pathway to independent practice for experienced NPs
• Category 103 NP: Independent practice in group settings after specified experience
• Category 104 NP: Fully independent after 3+ years, can practice solo
• PMHNPs can manage insomnia independently under this framework

Telehealth Prescribing:

• No state ban on telehealth prescribing of Schedule III–V controlled substances
• Schedule II via telehealth discouraged without prior in-person exam (professional standard, not statutory ban)
• ‘Appropriate prior examination’ required but can be done via telehealth if meets standard of care
• CURES PDMP check mandatory before first prescription of Schedule II–IV and every 4 months if continuing

Electronic Prescribing:

• Mandatory for all controlled substances (2022 requirement)
• Need EPCS-enabled system

Insomnia-Specific Considerations:

• Most insomnia meds (Schedule IV) can be prescribed via telehealth without issue
• Document thorough video evaluation
• Check CURES before prescribing zolpidem, benzodiazepines, or any controlled sleep med
• Obtain telehealth consent per CA law

Market Opportunity:

• High demand, provider shortages in rural areas
• Telehealth parity laws (Medi-Cal and private insurance)
• Large, diverse population — multilingual providers in demand

Texas

Licensing:

• Member of IMLC (physicians can expedite licensing)
• APRNs need Texas license + Prescriptive Authority Agreement with physician
• Enhanced Nurse Licensure Compact for RNs (not APRNs)

NP Scope:

• Restricted practice state
• PMHNPs must have written Prescriptive Authority Agreement with Texas physician
• Physician oversight required (not co-sign, but periodic review)
• Cannot prescribe Schedule II in outpatient settings (hospital/hospice only)
• One physician can supervise maximum 7 NPs

Telehealth Prescribing:

• 2017 reform (SB 1107) opened telehealth significantly
• Provider-patient relationship can be established via telehealth
• CRITICAL: Prohibition on controlled substances for chronic pain via telehealth (TMB Rule 174)
• This does NOT apply to insomnia (insomnia is not ‘pain management’)
• Insomnia providers can prescribe benzodiazepines, z-drugs via telehealth legally
• PMP check required before prescribing opioids, benzodiazepines, barbiturates, or any Schedule III–V (as of 2021)
• Electronic prescribing mandatory for all controlled substances

Insomnia-Specific Considerations:

• Texas chronic pain telemedicine ban does NOT affect insomnia treatment
• Check Texas PMP (AWARxE) before prescribing any benzodiazepine or z-drug
• NPs can prescribe Schedule IV sleep meds under physician delegation
• Document that treatment is for insomnia/sleep disorder, not pain
• Avoid any perception of prescribing sedatives for pain management

Market Opportunity:

• Large state with urban centers and vast rural areas
• Provider shortages outside major cities
• High veteran population (insomnia common)
• Regulatory environment favorable post-2017 reforms
• NP independence is limited — psychiatrists may have competitive edge

Florida

Licensing:

• Unique: Out-of-state providers can register as Florida Telehealth Provider without full licensure (FL Statute 456.47)
• Requires unrestricted license in another state + application
• Florida is in IMLC (physicians) and RN Compact (not APRN)

NP Scope:

• Restricted practice for PMHNPs
• Autonomous APRN statute (2020) only covers primary care NPs — psychiatric NPs excluded
• PMHNPs require supervising psychiatrist or physician protocol
• Pending legislation (SB 758 in 2025) to extend autonomy to psych NPs — not yet passed as of 2026
• Only ‘psychiatric nurses’ (PMHNPs with specific training) can prescribe controlled psychotropics to minors

Telehealth Prescribing:

• CRITICAL RESTRICTION: Florida law prohibits prescribing controlled substances via telehealth EXCEPT for:

1. Treatment of psychiatric disorder
2. Inpatient hospital care
3. Hospice care
4. Nursing home residents

• Insomnia qualifies under ‘psychiatric disorder’ exception (DSM-5 diagnosis)
• Must document psychiatric nature of insomnia in medical record
• E-FORCSE PDMP check mandatory before prescribing any controlled substance to patient ≥16 years old

Insomnia-Specific Considerations:

• You CAN prescribe Schedule IV sleep medications via telehealth by documenting insomnia as psychiatric condition
• Code as ‘Insomnia Disorder’ (DSM-5) in documentation
• Check E-FORCSE before every controlled substance prescription
• Supervising physician required for PMHNP practice
• Leverage Florida’s telehealth registration if you’re out-of-state

Market Opportunity:

• Large elderly population with high insomnia prevalence
• Snowbirds who use telehealth when traveling
• Telehealth registration allows multi-state practices to serve FL patients
• Major metros (Miami, Tampa, Orlando) have provider availability; rural north Florida underserved

New York

Licensing:

• NOT in IMLC — must obtain full NY medical license
• APRNs need NY RN + NP certification (not in APRN Compact)

NP Scope:

• Full Practice Authority after 3,600 hours (about 2 years full-time)
• NP Modernization Act made permanent in 2022
• Before 3,600 hours: written collaborative agreement with physician required
• After 3,600 hours: independent practice, only maintain ‘collaborative relationships’ (much looser)
• Experienced PMHNPs can run independent insomnia practices

Telehealth Prescribing:

• No state prohibition on telehealth prescribing of controlled substances
• Defers to federal Ryan Haight Act requirements
• Standard of care via telehealth expected (proper evaluation, documentation)
• ISTOP PDMP check required EVERY TIME prescribing Schedule II, III, or IV controlled substance
• Electronic prescribing mandatory for all medications (limited exceptions)

Insomnia-Specific Considerations:

• Check ISTOP before every zolpidem, benzodiazepine, or controlled sleep med prescription
• Document thorough telehealth evaluation
• Obtain patient consent for telehealth
• NY is aggressive about PDMP monitoring — strict compliance essential
• If patient needs in-person consultation or referral, facilitate it

Market Opportunity:

• NYC and suburbs have provider concentration but massive demand (long waitlists)
• Upstate rural areas face provider shortages
• Strong telehealth parity laws (Medicaid and private insurance)
• Government and insurers supportive of telehealth mental health
• Experienced NPs with FPA can scale independent insomnia practices

Pennsylvania

Licensing:

• Member of IMLC (physicians)
• APRNs need PA RN + CRNP license (no APRN Compact)
• No special telehealth license

NP Scope:

• Reduced practice state
• PMHNPs must have collaborative agreement with physician for prescriptive authority
• Physician doesn’t co-sign every prescription but must be available for consultation
• Agreement must detail what NP can prescribe
• Chart review required (percentage specified in agreement)

Telehealth Prescribing:

• No state law explicitly restricting controlled substances via telehealth
• Defers to federal Ryan Haight Act
• Medical and Osteopathic Boards: physician-patient relationship can be established via telemedicine if standard of care upheld
• ABC-MAP PDMP check required before prescribing opioid or benzodiazepine the first time AND for every subsequent prescription/refill
• Recommended to check PDMP for all controlled substances (including z-drugs)

Insomnia-Specific Considerations:

• Check PA PDMP before prescribing any benzodiazepine sleep medication (legally required)
• Recommended to check for z-drugs (zolpidem) even though not strictly mandated
• Collaborative agreement essential for NPs — must have physician partner on record
• Document thorough video evaluation (PA boards emphasize proper exam via telehealth)
• Follow same standard of care as in-person

Market Opportunity:

• Urban areas (Philadelphia, Pittsburgh) well-served; rural central PA underserved
• Telehealth expansion focus for mental health in rural areas
• Insomnia often undiagnosed in primary care — specialist niche available
• No comprehensive telehealth statute yet (pending legislation) — operate under board guidance

Illinois

Licensing:

• Member of IMLC (physicians)
• APRNs need Illinois license (not in APRN Compact)

NP Scope:

• Full Practice Authority available
• APRNs can apply for FPA after 4,000 hours practice + additional training
• FPA grants independent practice and prescriptive authority including controlled substances
• Without FPA: written collaborative agreement with physician required
• IL allows NPs with collaboration to prescribe Schedule III–V and certain Schedule II (30-day supply if delegated)

Telehealth Prescribing:

• No state restrictions on telehealth prescribing beyond standard of care
• Telehealth exam sufficient to establish patient relationship
• 2021 Telehealth Act (HB 3308): permanent audio-only mental health coverage, insurance parity protections
• PMP check required before prescribing controlled substances (mandatory for opioids initially, strongly encouraged for all)
• Electronic prescribing of controlled substances mandated (aligned with federal Medicare requirements)

Insomnia-Specific Considerations:

• FPA NPs can practice independently — no physician oversight needed
• Check Illinois PDMP (PMPnow) before prescribing (especially opioids, recommended for all controls)
• Document proper telehealth evaluation
• IL law progressive on telehealth — minimal barriers
• Medicaid and private insurers cover telehealth at parity

Market Opportunity:

• Chicago and suburbs have provider concentration but high demand
• Downstate Illinois (central, southern) face provider shortages — telehealth fills gap
• Many APRNs practicing independently (increasing provider availability)
• Progressive telehealth laws and NP scope favorable for insomnia-focused practices

State Comparison Table: Key Regulations for Insomnia Prescribing

The Economics of Telehealth Insomnia Practice

Let’s talk about the business reality: Can you actually build a sustainable practice treating insomnia via telehealth?

The DIY Marketing Reality

Many providers assume they can acquire patients cheaply through SEO, Google Ads, or directory listings. The truth is more expensive:

Realistic Patient Acquisition Costs:

• Google Ads: $15–40+ per click for mental health keywords; most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–400+
• SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience
• Directory Listings: Psychology Today, Zocdoc charge monthly fees AND you compete with hundreds of other providers. Zocdoc charges per booking ($35–100+) but total monthly cost including subscription adds up
• Total CAC when factoring all costs: $200–500+ per patient when you include agency fees, ad spend testing, staff time to qualify leads, no-show rates, months of SEO investment, and failed campaigns

The Hidden Costs:

• Staff time handling and qualifying leads
• No-show rates from cold leads (often 30–40% for first appointments)
• Months of marketing investment before seeing results
• Expertise gap (most psychiatrists and NPs aren’t digital marketers)

The Klarity Health Model: Pay Only When You See Patients

Instead of spending $3,000–5,000/month on marketing with uncertain results, Klarity uses a pay-per-appointment model:

How it works:

• Standard listing fee per new patient lead (similar to Zocdoc)
• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Why this makes economic sense:

• Guaranteed ROI vs. gambling on marketing channels
• Remove the patient acquisition risk entirely
• Focus on clinical care, not digital marketing
• Scale patient volume without scaling marketing budget
• Especially valuable for providers starting out or in restricted-practice states (where you’re already paying a supervising physician)

Reality check: DIY marketing can eventually be cost-effective IF you have the budget ($5K+/month), expertise (or hire an agency), and patience (6–12 months before ROI). For most providers — especially those starting out, scaling, or in states requiring physician collaboration — a platform that handles patient acquisition is simply the smart business choice.

What’s Next: Preparing for Permanent DEA Rules

The current telehealth flexibilities expire December 31, 2026. Here’s what to expect and how to prepare:

Likely Changes

Special Registration Requirement:

• DEA will probably require a ‘Telemedicine Special Registration’ to prescribe Schedule III–V without in-person exams
• Cost and application process TBD
• Should be available to all DEA-registered practitioners

Advanced Registration for Schedule II:

• Only certain specialists (including psychiatrists) can prescribe Schedule II via telehealth
• PMHNPs may be included or may need additional qualifications
• National PDMP integration likely

Possible Return of In-Person Exam Requirement:

• Some scenarios may require at least one in-person visit for long-term controlled substance treatment
• Likely exemptions for mental health treatment (including insomnia)

How to Prepare

Now (2026):

• Build your telehealth insomnia practice under current flexibilities
• Establish robust clinical documentation practices
• Maintain strict PDMP compliance in every state
• Stay current on state scope of practice changes
• Join professional organizations that track DEA rulemaking

When New Rules Drop (likely 2027):

• Apply for special registration immediately (don’t wait for the deadline)
• Review and update your telehealth protocols
• Ensure your EHR/EPCS system is compliant
• Budget for registration fees
• Consider multi-state licensure strategy (IMLC for physicians where available)

Long-term:

• Diversify treatment offerings (include non-controlled options like CBT-I, trazodone)
• Build systems that can adapt to regulatory changes
• Maintain relationships with supervising physicians (if NP in restricted state)
• Document everything — your clinical reasoning is your best legal defense

Frequently Asked Questions

Can I prescribe Ambien (zolpidem) via telehealth in 2026?
Yes. Under current federal DEA rules (extended through December 31, 2026), you can prescribe Schedule IV sleep medications like zolpidem via telehealth without an in-person exam. You must be licensed in the patient’s state, DEA-registered, and follow state-specific requirements (PDMP checks, e-prescribing, etc.).

Do I need a physician to supervise me as a PMHNP treating insomnia?
It depends on your state. In full-practice states like New York (after 3,600 hours) and Illinois (with FPA), you can practice independently. In restricted states like Texas, Florida, and Pennsylvania, you need a collaborative agreement or supervising physician. Check your state’s specific requirements above.

Can I prescribe benzodiazepines for insomnia via telehealth?
Yes, in most states, as long as you follow PDMP requirements and document appropriate clinical reasoning. Some states (like Texas) prohibit controlled substances via telehealth for ‘chronic pain’ — but insomnia doesn’t fall under that restriction. Florida requires you document insomnia as a psychiatric disorder to prescribe controlled substances via telehealth.

What’s the difference between Schedule II and Schedule IV for prescribing purposes?
Schedule II substances (stimulants, opioids) have stricter rules: no refills allowed, often require special state authorizations for telehealth. Schedule IV substances (most insomnia meds) allow up to 5 refills in 6 months and have fewer telehealth restrictions. Most insomnia medications are Schedule IV, making them easier to prescribe via telehealth.

Do I have to check the PDMP every time I prescribe a sleep medication?
It varies by state. New York and Pennsylvania require PDMP checks for every controlled substance prescription (including refills of benzodiazepines). California requires checks before the first prescription and every 4 months. Texas requires checks before prescribing benzodiazepines or any Schedule III–V. Illinois strongly recommends it. Check your state’s specific requirement in the table above.

Can I see patients in multiple states via telehealth?
Only if you’re licensed in each state where patients are located. Physicians can use the Interstate Medical Licensure Compact in member states. NPs generally must obtain individual state licenses (no active APRN compact yet). Some states like Florida offer telehealth registration for out-of-state providers.

What happens if the DEA flexibilities expire and I haven’t gotten the new registration?
Legally, you’d need an in-person exam before prescribing controlled substances via telehealth (reverting to pre-COVID Ryan Haight Act rules). Practically, DEA will likely provide a grace period or grandfather existing telehealth relationships. Stay alert for DEA announcements as 2026 progresses — they’ve extended flexibilities repeatedly to avoid disruption.

Is treating insomnia via telehealth actually profitable?
Yes, if you avoid the patient acquisition cost trap. Direct marketing typically costs $200–500+ per patient when you factor in all expenses. Platforms like Klarity that use a pay-per-appointment model eliminate upfront marketing spend and only charge when you see patients — making the economics much more favorable, especially when starting out.

Join Klarity’s Provider Network

If you’re a psychiatrist or PMHNP looking to treat insomnia patients via telehealth without the headache of marketing, patient acquisition, or platform fees, Klarity Health removes those barriers entirely.

What you get:

• Pre-qualified insomnia patients matched to your availability
• No upfront marketing costs or monthly fees
• Simple pay-per-appointment model
• Built-in telehealth platform (HIPAA-compliant, includes EHR)
• Both insurance and cash-pay patient flow
• Compliance support for multi-state practice
• You set your schedule and control your patient volume

**Who

Source:

• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=WASHINGTON%20%E2%80%93%C2%A0The%20U,flexibilities%20through%20December%2031%2C%202026
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=Under%20these%20telemedicine%20flexibilities%2C%20DEA,applicable%20federal%20and%20state%20law
• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=During%20the%20COVID,person%20evaluation%20of%20that%20patient
• https://www.dlapiper.com/en-th/insights/publications/2024/11/dea-and-hhs-issue-third-temporary-extension-of-telemedicine-flexibilities#:~:text=Further%2C%20as%20the%20Third%20Temporary,monitor%20this%20space%20for%20updates
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=ever%20having%20an%20in,specialized%20medical%20providers%20to%20issue
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=New%20York%20State%20Education%20Law,to%20practice%20under%20physician%20supervision
• https://idfpr.illinois.gov/profs/nursing.html#:~:text=,APN%20Controlled%20Substance
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=Nurse%20practitioners%2C%20however%2C%20must%20practice,or%20certified%20NP%20as%20follows
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=also%20are%20psychiatric%20nurses%20as,455
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=provider%20may%20not%20use%20telehealth,in%20Schedule%20II%20of%20s